Grand Vision for FY2028: “Continuing to protect people’s health as a global clinical diagnostics company”
First written in FY2019. 2 of 4 entries say "Reframed", first in FY2022. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「To respond to changes in the business environment and incorporate a sustainability management perspective, the Group has established “EIKEN Vision 2030” as its vision for 2030.」
The name and framework were updated from the Grand Vision, “Continuing to protect people's health as a global clinical diagnostics company,” targeted for fiscal 2028, to the vision for 2030, “EIKEN Vision 2030.” - FY2022ReframedAnnual report
「To respond to changes in the business environment and incorporate a sustainability management perspective, the Group reviewed its management vision “EIKEN ROAD MAP 2019” and redefined it as “EIKEN ROAD MAP 2030,” with 2030 as the target year.」
The framework was updated from EIKEN ROAD MAP 2019, based on the previous Grand Vision for fiscal 2028, to a new roadmap targeting 2030. - FY2020RestatedAnnual report
「Over the 10 years through fiscal 2028, the 90th anniversary of our founding, we aim to achieve the Grand Vision, “Saving Your Health (Continuing to protect people's health as a global clinical diagnostics company).”」
The Grand Vision with fiscal 2028 as its target year continues to underpin EIKEN ROAD MAP 2019 and the medium-term management plan. - FY2019First statedAnnual report
「Under the new EIKEN ROAD MAP 2019, we formulated the following basic strategies to achieve the Group's Grand Vision for fiscal 2028, the 90th anniversary of its founding: “Continuing to protect people's health as a global clinical diagnostics company.”」
A new long-term corporate vision with fiscal 2028 as its target year was presented for the first time under EIKEN ROAD MAP 2019.